Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points (p<0.0001, n=10) and 100% of patients in remission at Day 8Primary...
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.81 | -9 | 9 | 9 | 8.021 | 97807 | 8.49101895 | CS |
| 4 | -0.01 | -0.121951219512 | 8.2 | 10.23 | 6.72 | 99105 | 8.05276508 | CS |
| 12 | -0.1 | -1.20627261761 | 8.29 | 11.09 | 6.72 | 74743 | 8.43531429 | CS |
| 26 | -3.71 | -31.1764705882 | 11.9 | 14 | 6 | 56623 | 8.62540346 | CS |
| 52 | 2.28 | 38.578680203 | 5.91 | 14.99 | 5.5 | 74753 | 9.41344212 | CS |
| 156 | -10.61 | -56.4361702128 | 18.8 | 21.32 | 5.05 | 73659 | 10.53289436 | CS |
| 260 | -13.81 | -62.7727272727 | 22 | 30.43 | 5.05 | 81421 | 13.28577593 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
